Insulin regimens during type 1 diabetes pregnancy
- PMID: 36623519
- DOI: 10.1016/S2213-8587(22)00341-2
Insulin regimens during type 1 diabetes pregnancy
Conflict of interest statement
I declare being a member of the Medtronic European Scientific Advisory Board and receiving speaker honoraria from Dexcom, Abbott Diabetes Care, Medtronic, and Novo Nordisk.
Comment on
-
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial.Lancet Diabetes Endocrinol. 2023 Feb;11(2):86-95. doi: 10.1016/S2213-8587(22)00307-2. Epub 2023 Jan 6. Lancet Diabetes Endocrinol. 2023. PMID: 36623517 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical